Long-term safety of mepolizumab for up to ∼10 years in patients with severe asthma: open-label extension study (Annals of Medicine, 2024)

(untitled) - Pavord, I; Chan, R; Brown, N; Howarth, P; Gilson, M; Price, RG; Maspero, J